世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000033964

ヒト用混合ワクチンの世界市場(2023-2027)

TechNavio

Global Human Combination Vaccines Market 2023-2027

発刊日 2022/12/30

言語英語

体裁PDF/168ページ

ライセンス/価格168ページ

0000033964

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、ヒト用混合ワクチン市場を分析します。

世界のヒト用混合ワクチン市場は、予測期間中に約8.13 %のCAGRで増加し、2022年から2027年の間に60億4,698万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。

本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。市場は、抗ウイルス剤耐性の向上、小児人口の増加、感染症患者の増加によって牽引されています。

調査範囲

  • 市場セグメント
    ➣ タイプ別
      ◇ 不活化ワクチン
      ◇ 弱毒生ワクチン
    ➣ チャンネル別
      ◇ 病院
      ◇ 小売業者
      ◇ オンライン
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ その他の地域

本調査では、今後数年間におけるヒト用混合ワクチン市場の成長を促進する主要な理由の一つとして、バイオテロリズムによる脅威を挙げています。また、新しいワクチンの研究開発への関心の高まりや政府出資プログラムの存在も、市場の大きな需要につながるでしょう。

TechNavio社は、主要なパラメーターの分析による複数のソースからのデータの調査、合成、および合計によって、市場の詳細な状況を提示します。

本レポートは以下の分野をカバーしています。

  • ヒト用混合ワクチンの市場規模
  • ヒト用混合ワクチンの市場予測
  • ヒト用混合ワクチン市場の業界分析

TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要なヒト用混合ワクチン市場ベンダーの詳細な分析を提供します

  • 調査企業
    ➣ Abbott Laboratories
    ➣ Arabio
    ➣ Bharat Biotech Ltd.
    ➣ Biological E. Ltd.
    ➣ Cadila Healthcare Ltd.
    ➣ CSL Ltd.
    ➣ 第一三共(Daiichi Sankyo Co. Ltd.)
    ➣ GlaxoSmithKline Plc
    ➣ Grifols SA, LG Corp.
    ➣ 明治ホールディングス(Meiji Holdings Co. Ltd.)
    ➣ Merck and Co. Inc.
    ➣ Mitsubishi Chemical Holdings Corp.
    ➣ Panacea Biotec Ltd.
    ➣ Pfizer Inc.
    ➣ PT Bio Farma
    ➣ Sanofi SA
    ➣ Serum Institute of India Pvt. Ltd.
    ➣ 武田製薬工業(Takeda Pharmaceutical Co. Ltd.)
    ➣ Walvax Biotechnology Co. Ltd.

また、本レポートには、市場の成長に影響を与える今後の動向と課題に関する情報が含まれており、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。

TechNavio社について

TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global human combination vaccines market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global human combination vaccines market 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.3 Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Inactivated vaccine - Market size and forecast 2022-2027
Exhibit 34: Chart on Inactivated vaccine - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Inactivated vaccine - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Inactivated vaccine - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Inactivated vaccine - Year-over-year growth 2022-2027 (%)
6.4 Live attenuated vaccine - Market size and forecast 2022-2027
Exhibit 38: Chart on Live attenuated vaccine - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Live attenuated vaccine - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Live attenuated vaccine - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Live attenuated vaccine - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ million)

7 Market Segmentation by Channel
7.1 Market segments
Exhibit 43: Chart on Channel - Market share 2022-2027 (%)
Exhibit 44: Data Table on Channel - Market share 2022-2027 (%)
7.2 Comparison by Channel
Exhibit 45: Chart on Comparison by Channel
Exhibit 46: Data Table on Comparison by Channel
7.3 Hospitals - Market size and forecast 2022-2027
Exhibit 47: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
7.4 Retailers - Market size and forecast 2022-2027
Exhibit 51: Chart on Retailers - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Retailers - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Retailers - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Retailers - Year-over-year growth 2022-2027 (%)
7.5 Online - Market size and forecast 2022-2027
Exhibit 55: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Online - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Channel
Exhibit 59: Market opportunity by Channel ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 63: Chart on Geographic comparison
Exhibit 64: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 UK - Market size and forecast 2022-2027
Exhibit 85: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.9 Canada - Market size and forecast 2022-2027
Exhibit 89: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.10 Japan - Market size and forecast 2022-2027
Exhibit 93: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.11 Germany - Market size and forecast 2022-2027
Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 101: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 102: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 104: Overview on factors of disruption
11.4 Industry risks
Exhibit 105: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 106: Vendors covered
12.2 Market positioning of vendors
Exhibit 107: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 108: Abbott Laboratories - Overview
Exhibit 109: Abbott Laboratories - Business segments
Exhibit 110: Abbott Laboratories - Key news
Exhibit 111: Abbott Laboratories - Key offerings
Exhibit 112: Abbott Laboratories - Segment focus
12.4 Bharat Biotech Ltd.
Exhibit 113: Bharat Biotech Ltd. - Overview
Exhibit 114: Bharat Biotech Ltd. - Product / Service
Exhibit 115: Bharat Biotech Ltd. - Key news
Exhibit 116: Bharat Biotech Ltd. - Key offerings
12.5 Biological E. Ltd.
Exhibit 117: Biological E. Ltd. - Overview
Exhibit 118: Biological E. Ltd. - Product / Service
Exhibit 119: Biological E. Ltd. - Key offerings
12.6 Cadila Healthcare Ltd.
Exhibit 120: Cadila Healthcare Ltd. - Overview
Exhibit 121: Cadila Healthcare Ltd. - Business segments
Exhibit 122: Cadila Healthcare Ltd. - Key offerings
Exhibit 123: Cadila Healthcare Ltd. - Segment focus
12.7 CSL Ltd.
Exhibit 124: CSL Ltd. - Overview
Exhibit 125: CSL Ltd. - Business segments
Exhibit 126: CSL Ltd. - Key news
Exhibit 127: CSL Ltd. - Key offerings
Exhibit 128: CSL Ltd. - Segment focus
12.8 Daiichi Sankyo Co. Ltd.
Exhibit 129: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 130: Daiichi Sankyo Co. Ltd. - Business segments
Exhibit 131: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 132: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibit 133: Daiichi Sankyo Co. Ltd. - Segment focus
12.9 GlaxoSmithKline Plc
Exhibit 134: GlaxoSmithKline Plc - Overview
Exhibit 135: GlaxoSmithKline Plc - Business segments
Exhibit 136: GlaxoSmithKline Plc - Key offerings
Exhibit 137: GlaxoSmithKline Plc - Segment focus
12.10 Grifols SA
Exhibit 138: Grifols SA - Overview
Exhibit 139: Grifols SA - Business segments
Exhibit 140: Grifols SA - Key offerings
Exhibit 141: Grifols SA - Segment focus
12.11 LG Corp.
Exhibit 142: LG Corp. - Overview
Exhibit 143: LG Corp. - Business segments
Exhibit 144: LG Corp. - Key offerings
Exhibit 145: LG Corp. - Segment focus
12.12 Meiji Holdings Co. Ltd.
Exhibit 146: Meiji Holdings Co. Ltd. - Overview
Exhibit 147: Meiji Holdings Co. Ltd. - Business segments
Exhibit 148: Meiji Holdings Co. Ltd. - Key news
Exhibit 149: Meiji Holdings Co. Ltd. - Key offerings
Exhibit 150: Meiji Holdings Co. Ltd. - Segment focus
12.13 Merck and Co. Inc.
Exhibit 151: Merck and Co. Inc. - Overview
Exhibit 152: Merck and Co. Inc. - Business segments
Exhibit 153: Merck and Co. Inc. - Key news
Exhibit 154: Merck and Co. Inc. - Key offerings
Exhibit 155: Merck and Co. Inc. - Segment focus
12.14 Mitsubishi Chemical Holdings Corp.
Exhibit 156: Mitsubishi Chemical Holdings Corp. - Overview
Exhibit 157: Mitsubishi Chemical Holdings Corp. - Business segments
Exhibit 158: Mitsubishi Chemical Holdings Corp. - Key offerings
Exhibit 159: Mitsubishi Chemical Holdings Corp. - Segment focus
12.15 Pfizer Inc.
Exhibit 160: Pfizer Inc. - Overview
Exhibit 161: Pfizer Inc. - Product / Service
Exhibit 162: Pfizer Inc. - Key news
Exhibit 163: Pfizer Inc. - Key offerings
12.16 Sanofi SA
Exhibit 164: Sanofi SA - Overview
Exhibit 165: Sanofi SA - Business segments
Exhibit 166: Sanofi SA - Key news
Exhibit 167: Sanofi SA - Key offerings
Exhibit 168: Sanofi SA - Segment focus
12.17 Serum Institute of India Pvt. Ltd.
Exhibit 169: Serum Institute of India Pvt. Ltd. - Overview
Exhibit 170: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibit 171: Serum Institute of India Pvt. Ltd. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 172: Inclusions checklist
Exhibit 173: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 174: Currency conversion rates for US$
13.4 Research methodology
Exhibit 175: Research methodology
Exhibit 176: Validation techniques employed for market sizing
Exhibit 177: Information sources
13.5 List of abbreviations
Exhibit 178: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global human combination vaccines market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Inactivated vaccine - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Inactivated vaccine - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Inactivated vaccine - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Inactivated vaccine - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Live attenuated vaccine - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Live attenuated vaccine - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Live attenuated vaccine - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Live attenuated vaccine - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Chart on Channel - Market share 2022-2027 (%)
Exhibits44: Data Table on Channel - Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Channel
Exhibits46: Data Table on Comparison by Channel
Exhibits47: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Retailers - Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Retailers - Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Retailers - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Retailers - Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by Channel ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ million)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: Abbott Laboratories - Overview
Exhibits109: Abbott Laboratories - Business segments
Exhibits110: Abbott Laboratories - Key news
Exhibits111: Abbott Laboratories - Key offerings
Exhibits112: Abbott Laboratories - Segment focus
Exhibits113: Bharat Biotech Ltd. - Overview
Exhibits114: Bharat Biotech Ltd. - Product / Service
Exhibits115: Bharat Biotech Ltd. - Key news
Exhibits116: Bharat Biotech Ltd. - Key offerings
Exhibits117: Biological E. Ltd. - Overview
Exhibits118: Biological E. Ltd. - Product / Service
Exhibits119: Biological E. Ltd. - Key offerings
Exhibits120: Cadila Healthcare Ltd. - Overview
Exhibits121: Cadila Healthcare Ltd. - Business segments
Exhibits122: Cadila Healthcare Ltd. - Key offerings
Exhibits123: Cadila Healthcare Ltd. - Segment focus
Exhibits124: CSL Ltd. - Overview
Exhibits125: CSL Ltd. - Business segments
Exhibits126: CSL Ltd. - Key news
Exhibits127: CSL Ltd. - Key offerings
Exhibits128: CSL Ltd. - Segment focus
Exhibits129: Daiichi Sankyo Co. Ltd. - Overview
Exhibits130: Daiichi Sankyo Co. Ltd. - Business segments
Exhibits131: Daiichi Sankyo Co. Ltd. - Key news
Exhibits132: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits133: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibits134: GlaxoSmithKline Plc - Overview
Exhibits135: GlaxoSmithKline Plc - Business segments
Exhibits136: GlaxoSmithKline Plc - Key offerings
Exhibits137: GlaxoSmithKline Plc - Segment focus
Exhibits138: Grifols SA - Overview
Exhibits139: Grifols SA - Business segments
Exhibits140: Grifols SA - Key offerings
Exhibits141: Grifols SA - Segment focus
Exhibits142: LG Corp. - Overview
Exhibits143: LG Corp. - Business segments
Exhibits144: LG Corp. - Key offerings
Exhibits145: LG Corp. - Segment focus
Exhibits146: Meiji Holdings Co. Ltd. - Overview
Exhibits147: Meiji Holdings Co. Ltd. - Business segments
Exhibits148: Meiji Holdings Co. Ltd. - Key news
Exhibits149: Meiji Holdings Co. Ltd. - Key offerings
Exhibits150: Meiji Holdings Co. Ltd. - Segment focus
Exhibits151: Merck and Co. Inc. - Overview
Exhibits152: Merck and Co. Inc. - Business segments
Exhibits153: Merck and Co. Inc. - Key news
Exhibits154: Merck and Co. Inc. - Key offerings
Exhibits155: Merck and Co. Inc. - Segment focus
Exhibits156: Mitsubishi Chemical Holdings Corp. - Overview
Exhibits157: Mitsubishi Chemical Holdings Corp. - Business segments
Exhibits158: Mitsubishi Chemical Holdings Corp. - Key offerings
Exhibits159: Mitsubishi Chemical Holdings Corp. - Segment focus
Exhibits160: Pfizer Inc. - Overview
Exhibits161: Pfizer Inc. - Product / Service
Exhibits162: Pfizer Inc. - Key news
Exhibits163: Pfizer Inc. - Key offerings
Exhibits164: Sanofi SA - Overview
Exhibits165: Sanofi SA - Business segments
Exhibits166: Sanofi SA - Key news
Exhibits167: Sanofi SA - Key offerings
Exhibits168: Sanofi SA - Segment focus
Exhibits169: Serum Institute of India Pvt. Ltd. - Overview
Exhibits170: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibits171: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibits172: Inclusions checklist
Exhibits173: Exclusions checklist
Exhibits174: Currency conversion rates for US$
Exhibits175: Research methodology
Exhibits176: Validation techniques employed for market sizing
Exhibits177: Information sources
Exhibits178: List of abbreviations

この商品のレポートナンバー

0000033964

TOP